David Wise
NYU Langone Health · New York Langone Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David Wise as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:31 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05682443 · ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPCOncoC4, Inc. · active not recruiting · Metastatic Castration-resistant Prostate Cancer · principal investigator
- Ph1/Ph2NCT03837353 · A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1NYU Langone Health · terminated · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 16 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:31 UTC. The ranking covers the 200 most relevant of 9 PubMed records, and a shared surname and initials can bring in a namesake. All 9 on PubMed
- Oral Vaccination of Channel Catfish against Enteric Septicemia of Catfish Using a Live Attenuated Edwardsiella ictaluri Isolate.J Aquat Anim Health · 201540 citationsRCR 2.1
- Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.Eur Urol Oncol · 202324 citationsRCR 1.8
- The accuracy of external blood loss estimation by ambulance and hospital personnel.Emerg Med (Fremantle) · 200321 citationsRCR 1.0
- TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.JCO Precis Oncol · 202415 citationsRCR 1.8
- Effects of variable periods of food deprivation on the development of enteric septicemia in channel catfish.J Aquat Anim Health · 200814 citationsRCR 0.5
- Equal Improvement in Men and Women in the Treatment of Urologic Chronic Pelvic Pain Syndrome Using a Multi-modal Protocol with an Internal Myofascial Trigger Point Wand.Appl Psychophysiol Biofeedback · 201614 citationsRCR 1.0
- Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.Contemp Clin Trials · 202210 citationsRCR 0.5
- A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).Prostate Cancer Prostatic Dis · 202510 citationsRCR 2.6
- Iron status of channel catfish Ictalurus punctatus affected by channel catfish anemia and response to parenteral iron.Dis Aquat Organ · 20145 citationsRCR 0.2